Thyroidectomy Clinical Trials

Clinical trials related to Thyroidectomy Procedure

ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

Who is this study for? Patients with Thyroid Cancer
What treatments are being studied? Total Thyroidectomy
Status: Active_not_recruiting
Location: See all (20) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

Prospective randomized open phase III non-inferiority trial in cT1bT2N0 papillary thyroid carcinoma comparing: total thyroidectomy alone (experimental group) versus total thyroidectomy + Prophylactic Neck Dissection PND (reference group). Pre-registered patients will be randomized before surgery for tumors with class-6 cytology (Bethesda) or in the operating room after confirmation of malignancy by frozen section analysis for tumors with class-5 cytology.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Thyroid nodule measuring 11-40 mm on ultrasound (cT1bT2)

‣ AND with fine-needle aspiration biopsy (FNAB) cytology in favor of papillary thyroid carcinoma (Type 6 according to the Bethesda classification (or BRAF mutation found on cytology analysis) (Appendix 2)

⁃ OR with FNAB cytology suspicious for malignancy (Type 5 according to the Bethesda classification). In this latter case, randomization will be performed if confirmation of papillary carcinoma on intraoperative frozen section analysis

• cN0: absence of lymph nodes suspicious for malignancy on pre- operative ultrasound performed by the center's designated radiologist according to a standardized report

• Absence of a medical contra indication to performing a total thyroidectomy with or without bilateral prophylactic neck dissection of the central compartment

• Women of childbearing potential should have a negative pregnancy test (serum or urine) before any radioiodine administration. Sexually active patients must agree to use an effective method of contraception or to abstain from sexual activity during the study and for at least 6 months after last dose of radioiodine.

• Patient affiliated to a social security regimen or beneficiary of such regimen

• Patients age ≥ 18 years old, french-speaking

• Patients should understand, sign and date the written informed consent form prior to any protocol specific procedures. Patients should be able and willing to comply with study visits.

Locations
Other Locations
France
CHU d'Angers
Angers
Hôpital Saint André
Bordeaux
Institut Bergonié
Bordeaux
Groupement Hospitalier Est
Bron
Centre François Baclesse
Caen
Jean Perrin
Clermont-ferrand
Centre Georges François Leclerc
Dijon
CH de Haguenau
Haguenau
CHU Lille, Hôpital Claude Huriez
Lille
CHU Nimes
Nîmes
CHU de Poitiers
Poitiers
CHU Reims - Hôpital Robert Debré
Reims
Institut Godinot
Reims
Centre Henri Becquerel
Rouen
Institut de Cancérologie Strasbourg
Strasbourg
CHU de Toulouse Hôpital Larrey
Toulouse
Institut Claudius Régaud
Toulouse
CHRU Nancy - Hôpitaux de Brabois
Vandœuvre-lès-nancy
Gustave Roussy
Villejuif
Guadeloupe
CHU de Pointe à Pitre
Les Abymes
Time Frame
Start Date: 2018-08-08
Completion Date: 2027-12
Participants
Target number of participants: 352
Treatments
Active_comparator: Group 1
total thyroidectomy with bilateral prophylactic central compartment (level VI) neck dissection as defined by the American Thyroid Association \[American Thyroid Association Surgery Working Group, Thyroid 2009\]. This is a standard treatment recognized by the French Society of Otolaryngology Head and Neck Surgery \[French Society of Otolaryngology Head and Neck Sugery\].
Experimental: Group 2
total thyroidectomy alone without neck dissection. This is recognized as a standard treatment by the Francophone Association of Endocrine Surgery
Sponsors
Leads: Gustave Roussy, Cancer Campus, Grand Paris

This content was sourced from clinicaltrials.gov